Sources of uncertainty originate from the panoply of glycemic targets, the complexity of drug therapy, the choice of the first drug, the ideal sequence of drugs after the first drug failure, the possible harms of anti-hyperglycemic drugs, the outcomes of treatment (surrogate versus clinical) and the hierarchy of risk factors to treat for preventing the vascular complications
Recent research has shown that ferroptosis may contribute to the development of complications associated with diabetes mellitus, including kidney disease [8], osteoporosis [9], encephalopathy [10], cardiomyopathy [11], retinopathy [12], and MASLD [13, 14]
These recommendations reflect strong data for A1C reduction, hypoglycemia mitigation, and time-in-range improvements
Men should also understand that GLP-1 medications work best when integrated into a broader plan that includes nutrition support, regular movement, and professional monitoring